Results 271 to 280 of about 198,086 (334)
Bilirubin Targeting WNK1 to Alleviate NLRP3‐Mediated Neuroinflammation
At physiological concentrations, bilirubin binds to the kinase domain of WNK1, thereby augmenting its activity and facilitating the phosphorylation of downstream SPAK/OSR1. This phosphorylation inhibits KCC2 activity, leading to elevate intracellular chloride levels in neurons.
Linfei Mao+14 more
wiley +1 more source
Advanced Strategies in Enhancing the Hepatoprotective Efficacy of Natural Products: Integrating Nanotechnology, Genomics, and Mechanistic Insights. [PDF]
Patel J+4 more
europepmc +1 more source
Ursolic acid drug-drug nanocrystals ameliorate cholestatic liver injury via inhibiting oxidative stress and regulating bile acid metabolism. [PDF]
Hu M+10 more
europepmc +1 more source
Utilizing rat kidney gene co-expression networks to enhance safety assessment biomarker identification and human translation. [PDF]
Kunnen SJ+16 more
europepmc +1 more source
MRI findings of confluent hepatic fibrosis caused by different etiologies. [PDF]
Yu D+6 more
europepmc +1 more source
Ferroptosis: action and mechanism of chemical/drug-induced liver injury
Drug-induced liver injury (DILI) is characterized by hepatocyte injury, cholestasis injury, and mixed injury. The liver transplantation is required for serious clinical outcomes such as acute liver failure. Current studies have found that many mechanisms
Li Zeng+8 more
semanticscholar +4 more sources
Chemical Probes for drug-induced Liver Injury Imaging
Drug-induced liver injury (DILI) has been a long-standing concern of modern medicine, and the single most frequent reason for drug nonapprovals and postapproval restrictions or withdrawals.
Jiang Tao, Pengfei Rong, Wei Wang
semanticscholar +5 more sources